Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients

BACKGROUND: Even after curative resection, the prognosis of pathological stage I non-small cell lung cancer (NSCLC) can be heterogeneous, and the use of adjuvant chemotherapy in these patients is controversial. We aimed to identify the prognostic factors and role of adjuvant chemotherapy in patholog...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thorac Cancer
Autors principals: Liu, Chia-Hsin, Peng, Yi-Jen, Wang, Hong-Hau, Chen, Ying-Chieh, Tsai, Chen-Liang, Chian, Chih-Feng, Huang, Tsai-Wang
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2015
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4567008/
https://ncbi.nlm.nih.gov/pubmed/26445611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12233
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars